Gabor Szanto
Budapest, BU 1475, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Development of dual V1a/V2 antagonists containing triazolobenzazepine scaffold.
Journal: European journal of medicinal chemistry
Published: October 02, 2024
Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist.
Journal: Journal of medicinal chemistry
Published: January 02, 2024
Novel-Type GABAB PAMs: Structure-Activity Relationship in Light of the Protein Structure.
Journal: ACS medicinal chemistry letters
Published: December 20, 2023
Discovery of New Heterocyclic Ring Systems as Novel and Potent V1A Receptor Antagonists.
Journal: ACS chemical neuroscience
Published: October 21, 2020
New V1a receptor antagonist. Part 1. Synthesis and SAR development of urea derivatives.
Journal: Bioorganic & medicinal chemistry letters
Published: July 01, 2020
New V1a receptor antagonist. Part 2. Identification and optimization of triazolobenzazepines.
Journal: Bioorganic & medicinal chemistry letters
Published: July 01, 2020
New P2X3 receptor antagonists. Part 1: Discovery and optimization of tricyclic compounds.
Journal: Bioorganic & medicinal chemistry letters
Published: June 02, 2016
New P2X3 receptor antagonists. Part 2: Identification and SAR of quinazolinones.
Journal: Bioorganic & medicinal chemistry letters
Published: June 02, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026